In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Illumina Inc’s stock clocked out at $91.0, down -4.24% from its previous closing price of $95.03. In other words, the price has decreased by -$4.24 from its previous closing price. On the day, 2.56 million shares were traded. ILMN stock price reached its highest trading level at $93.8 during the session, while it also had its lowest trading level at $88.02.
Ratios:
To gain a deeper understanding of ILMN’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.11 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.57. For the most recent quarter (mrq), Quick Ratio is recorded 1.41 and its Current Ratio is at 1.81. In the meantime, Its Debt-to-Equity ratio is 1.15 whereas as Long-Term Debt/Eq ratio is at 0.89.
On July 11, 2025, Scotiabank Downgraded its rating to Sector Perform which previously was Sector Outperform but kept the price unchanged to $125.
Citigroup reiterated its Neutral rating for the stock on March 04, 2025, while the target price for the stock was revised from $130 to $90.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 12 ’25 when Dhingra Ankur bought 6,100 shares for $81.21 per share. The transaction valued at 495,381 led to the insider holds 24,906 shares of the business.
Thaysen Jacob bought 6,500 shares of ILMN for $525,732 on May 12 ’25. The Chief Executive Officer now owns 77,540 shares after completing the transaction at $80.88 per share. On May 13 ’25, another insider, Thaysen Jacob, who serves as the Chief Executive Officer of the company, bought 5,850 shares for $80.84 each. As a result, the insider paid 472,942 and bolstered with 83,390 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ILMN now has a Market Capitalization of 14606111744 and an Enterprise Value of 15429699584. As of this moment, Illumina’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.53, and their Forward P/E ratio for the next fiscal year is 18.77. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.11. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.27 while its Price-to-Book (P/B) ratio in mrq is 6.21. Its current Enterprise Value per Revenue stands at 3.602 whereas that against EBITDA is 13.559.
Stock Price History:
The Beta on a monthly basis for ILMN is 1.40, which has changed by -0.36757243 over the last 52 weeks, in comparison to a change of 0.13724327 over the same period for the S&P500. Over the past 52 weeks, ILMN has reached a high of $156.66, while it has fallen to a 52-week low of $68.70. The 50-Day Moving Average of the stock is -7.22%, while the 200-Day Moving Average is calculated to be -6.12%.
Shares Statistics:
It appears that ILMN traded 1.74M shares on average per day over the past three months and 1562180 shares per day over the past ten days. A total of 154.00M shares are outstanding, with a floating share count of 149.41M. Insiders hold about 2.79% of the company’s shares, while institutions hold 102.05% stake in the company. Shares short for ILMN as of 1759190400 were 6607099 with a Short Ratio of 3.80, compared to 1756425600 on 7215892. Therefore, it implies a Short% of Shares Outstanding of 6607099 and a Short% of Float of 6.69.
Earnings Estimates
Its stock is currently analyzed by 18.0 different market analysts. The consensus estimate for the next quarter is $1.17, with high estimates of $1.2 and low estimates of $1.1.
Analysts are recommending an EPS of between $4.55 and $4.43 for the fiscal current year, implying an average EPS of $4.5. EPS for the following year is $4.85, with 20.0 analysts recommending between $5.13 and $4.64.
Revenue Estimates
In . The current quarter, 16 analysts expect revenue to total $1.07B. It ranges from a high estimate of $1.07B to a low estimate of $1.06B. As of . The current estimate, Illumina Inc’s year-ago sales were $1.08BFor the next quarter, 16 analysts are estimating revenue of $1.09B. There is a high estimate of $1.12B for the next quarter, whereas the lowest estimate is $1.08B.
A total of 18 analysts have provided revenue estimates for ILMN’s current fiscal year. The highest revenue estimate was $4.3B, while the lowest revenue estimate was $4.24B, resulting in an average revenue estimate of $4.26B. In the same quarter a year ago, actual revenue was $4.37BBased on 18 analysts’ estimates, the company’s revenue will be $4.37B in the next fiscal year. The high estimate is $4.45B and the low estimate is $4.31B.
